Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 9/20 | 0.53 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2194934 | 0.88 | FAAH (0.63) | F10FAAHF2ELANEMEN1 | |
| SCHEMBL12509154 | 0.88 | FAAH (0.58) | F10CYP2C19FAAHMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL2197108 | 0.87 | FAAH (0.62) | F10FAAHF2ELANEMEN1 | |
| SCHEMBL12509210 | 0.87 | FAAH (0.63) | F10FAAHF2ELANEMEN1 | |
| SCHEMBL12508794 | 0.87 | FAAH (0.58) | F10FAAHF2ELANEMEN1 | |
| SCHEMBL12508496 | 0.87 | FAAH (0.51) | F10FAAHF2ELANESGMS2 | |
| SCHEMBL12509340 | 0.86 | F10 (0.57) | F10FAAHF2ELANESGMS2 | |
| SCHEMBL12508779 | 0.86 | FAAH (0.52) | F10FAAHF2ELANEMEN1 | |
| SCHEMBL12509358 | 0.85 | FAAH (0.53) | F10FAAHF2ELANEMEN1 | |
| SCHEMBL12508494 | 0.84 | FAAH (0.51) | F10FAAHF2ELANEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172230-A1 | UREA COMPOUND OR SALT THEREOF | FAAH, FAAH2, UTS2R | F10 1851/4885CYP2C9 2569/4885CYP2C19 2111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.